Advanced Protein Drugs and Formulations
- 1 January 2022
- journal article
- editorial
- Published by Bentham Science Publishers Ltd. in Current Protein & Peptide Science
- Vol. 23 (1) , 2-5
Abstract
: Previously, the application of proteins was uncommon as therapeutically active molecules. Some of the first applications of proteins as drugs have been insulin and vaccines for overcoming a physiological deficiency and the prevention of diseases, respectively. Nowadays, proteins have many applications, not only as drugs but also as drug delivery systems to be administered by different routes. Due to their nature, the behavior of proteins varies while the conditions of the environment are modified. For this reason, it is necessary to study their behavior for predicting the correct manufacturing, storing, or combination with other possible molecules in a formulation or into the body. The application of techniques for predicting the behavior of proteins in different environments has led to associating this type of behavior into the body with the occurrence of diseases, such as celiac disease or Alzheimer's disease. Thus, this work shows an overview of the main types of proteins applied as active therapeutically molecules, proteins-based drug delivery systems, and techniques for predicting their stability into the primary storing container and the body.Keywords
This publication has 25 references indexed in Scilit:
- Hematopoietic Growth Factors in Myelodysplastic SyndromesSeminars in Oncology, 2011
- Protein aggregation diseases: pathogenicity and therapeutic perspectivesNature Reviews Drug Discovery, 2010
- Impact of Adherence to Interferons in the Treatment of Multiple SclerosisClinical Drug Investigation, 2010
- Protein delivery: from conventional drug delivery carriers to polymeric nanoreactorsExpert Opinion on Drug Delivery, 2009
- Protein therapeutics: a summary and pharmacological classificationNature Reviews Drug Discovery, 2008
- CetuximabDrugs, 2007
- Pharmacokinetic aspects of biotechnology productsJournal of Pharmaceutical Sciences, 2004
- Trends in development and approval times for new therapeutics in the United StatesNature Reviews Drug Discovery, 2003
- Interferon-α treatment of hepatitis C virus-associated mixed cryoglobulinemiaJournal of Hepatology, 1997
- The use of hematopoietic growth factors in treating HIV infectionCurrent Opinion in Hematology, 1995